GlycoMimetics Inc is a clinical-stage biotechnology company... Show more
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where GLYC declined for three days, in of 304 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Aroon Indicator for GLYC entered a downward trend on June 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GLYC advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .
a developer of drugs to treat inflammatory diseases and cancer
Industry Biotechnology